SYK STRYKER CORPORATION

Stryker announces new Investor Relations leader

Stryker announces new Investor Relations leader

Kalamazoo, Michgan, March 02, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Preston Wells will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective June 1, 2020. After a very successful thirteen-year period, Katherine Owen, Vice President, Strategy and Investor Relations has decided to retire to spend more time with her family. In order to assure a smooth transition of her responsibilities, Ms. Owen will transition to Advisor to the Chief Executive Officer through March 30, 2021.

“We would like to thank Katherine for the many significant contributions she has made to our company and for her demonstrated commitment to our success and growth,” said Kevin Lobo, Stryker’s Chairman and Chief Executive Officer. “Katherine has strengthened our investor relations and business development capabilities, including the completion of many successful value-creating deals. I wish Katherine the very best in this new chapter of her life."

Mr. Wells has held leadership roles in finance for more than 20 year in various industries, including healthcare. He has served as Stryker’s Vice President, Financial Planning and Analysis since 2016 and has successfully transformed the company’s financial forecasting and budgeting processes. Mr. Wells has also worked closely with the company’s investor relations team to ensure a cohesive approach to investor reporting.

Prior to this role, Mr. Wells supported Stryker’s spine business as Senior Director of Finance where he was responsible for all aspects of sales operations, sales finance, financial planning and analysis and business unit finance. Mr. Wells previously served as the Chief Financial Officer at Dialight Corporation, a $300 million manufacturer of LED lighting and held senior leadership positions at Johnson & Johnson’s US consumer skincare business and UK reconstructive business.

Mr. Wells graduated Bucknell University with a bachelor’s degree in accounting and earned his MBA in supply chain management from Lehigh University.

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at .

Contacts

For investor inquiries please contact:

Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or

For media inquiries please contact:

Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or

EN
02/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRYKER CORPORATION

Stryker Corp: 1 director

A director at Stryker Corp sold 500,000 shares at 363.439USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

 PRESS RELEASE

Stryker declares an $0.88 per share quarterly dividend

Stryker declares an $0.88 per share quarterly dividend Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services i...

 PRESS RELEASE

Stryker reports 2025 operating results and 2026 outlook

Stryker reports 2025 operating results and 2026 outlook Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitio...

 PRESS RELEASE

Stryker to announce financial results for its fourth quarter and full ...

Stryker to announce financial results for its fourth quarter and full year 2025 Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026.  A press release will be issued at approximately 4:05 p.m. ET and available at that day. The press release will include summary financial information for the company’s fourth quarter and full year that ended December 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, January 29, 2026, to discuss its fo...

 PRESS RELEASE

Stryker declares an $0.88 per share quarterly dividend

Stryker declares an $0.88 per share quarterly dividend Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.  “We remain confident in our ability to deliver strong financial performance, and consistent with our capital allocation priorities we are increasing our dividend to $0.88 per share,” said Kevin Lobo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch